IGA HAND AND FOOT EFFICACY RESULTS
Not an actual patient.
As many patients
taking DUPIXENT achieved skin clearance at Week 16 vs placebo1,2
taking DUPIXENT achieved skin
clearance at Week 16 vs placebo1,2
Consider the BURDEN
that
SMALL BSA
involvement
can have3-5
Not an actual patient.
Adult patient 1–Achieved a 3-point improvement in IGA HAND AND FOOT SCORE
Change you can see
This adult patient was an actual patient (not a clinical trial patient) treated with DUPIXENT. Scoring was designated by
the treating physician. Because this was a real-world patient, other factors, including concomitant therapies, may
have influenced their treatment results, and individual results may vary.
RESULTS
ADULT PATIENT 2–ACHIEVED A 3-POINT IMPROVEMENT IN IGA HAND AND FOOT SCORE
This adult patient was an actual patient (not a clinical trial patient) treated with DUPIXENT. Scoring was designated by
the treating physician. Because this patient was a real world patient, other factors, including concomitant therapies,
may have influenced treatment results, and individual results may vary.
RESULTS
A clinical responder in the clinical trial of patients with uncontrolled moderate-to-severe atopic hand and foot
dermatitis was defined as a patient achieving IGA hand and foot 0 or 1.1